1. |
Schaaf L, Raue F. Multiple endocrine neoplasia. Dtsch Med Wochenschr, 2017, 142(18): 1379-1389.
|
2. |
Oberg K. Neuroendocrine tumors (NETs): historical overview and epidemiology. Tumori, 2010, 96(5): 797-801.
|
3. |
李祉丹, 郭锐, 张红梅, 等. 多发性内分泌腺瘤病 1 型患者基因突变分析. 中国实用内科杂志, 2010, 30(4): 343-345, 393.
|
4. |
张俊荣, 武悦, 王祥, 等. 多发性内分泌腺瘤病 15 例临床分析. 河南医学研究, 2018, 27(12): 2183-2186.
|
5. |
徐丹, 王薇, 韩兵, 等. 多发性内分泌腺瘤病 1 型 1 例及其家系的研究. 南昌大学学报(医学版), 2013, 53(3): 99-102, 106.
|
6. |
陈曦, 周光文. 多发性神经内分泌肿瘤诊断和治疗. 中国实用外科杂志, 2014, 34(6): 559-569.
|
7. |
Li X, Li M, Shi T, et al. Clinical implication of MEN1 mutation in surgically resected thymic carcinoid patients. J Thorac Dis, 2018, 10(2): E125-E129.
|
8. |
Trump D, Farren B, Wooding C, et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM, 1996, 89(9): 653-669.
|
9. |
Cardinal JW, Bergman L, Hayward N, et al. A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing. J Med Genet, 2005, 42(1): 69-74.
|
10. |
Thakker RV, Newey PJ, Walls GV, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab, 2012, 97(9): 2990-3011.
|
11. |
Schreinemakers JM, Pieterman CR, Scholten A, et al. The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review. World J Surg, 2011, 35(9): 1993-2005.
|
12. |
Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab, 2001, 86(12): 5658-5671.
|
13. |
Zhang HY, Chen NH, Zhang XK, et al. Clinical characteristics of multiple endocrime neoplasia: A analysis of 6 cases. Clin J Endocrinol Metab, 2013, 29(6): 470-473.
|
14. |
Gatta-Cherifi B, Chabre O, Murat A, et al. Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d’etude des Tumeurs Endocrines database. Eur J Endocrinol, 2012, 166(2): 269-279.
|